• Setting Recommendations for Good Practice of Health Technology Assessment in the Egyptian Ministry of Health

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Bevacizumab Compared to Cetuximab and Panitumumab in First-Line Treatment of Kras Wild-Type Metastatic Colorectal Cancer in France

    Nov 1, 2016, 00:00

  • Adherance To Medication Errors Repoting System At Public Hospital, Riyadh, Saudi Arabia

    Nov 1, 2016, 00:00

  • Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Tips Procedures with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Large Volume Paracentesis in Patients with Refractory Ascites – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Improving Access to Psychological Therapies in British Sign Language (BSL)- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- Past, Present and Future

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis- A Comparison Between Preset Artery Blood Samplers and Disposable Syringes in Arterial Blood Sampling

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)

    Nov 1, 2016, 00:00

  • Specialty Pharmacy, Diagnostic, And Genetic Testing Coverage In The United States

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Work Productivity Activity Impairment Loss of Patients with HER2 Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Direct Cost Of Hiv/Aids In Turkey

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • In-Hospital Mortality and Complications Following Surgical Resection of Glioblastoma

    Nov 1, 2016, 00:00

  • Personalized Mammography Screening and Screening Adherence - A Simulation of Cost-Effectiveness

    Nov 1, 2016, 00:00

  • Validation Of Comorbidity Indices (Charlson And Elixhauser) Computed In Cross Sectional Hospital Billing Data

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • A Unique Opportunity To Assess Quality-Of-Life Changes In Long-Term Waitlisted Bariatric Surgery Patients Using The Eq-5d-5l And Aqol-8d Multi-Attribute Utility Instruments Before And Three Months After Bariatric Surgery- An Exploratory Stu ...

    Nov 1, 2016, 00:00

  • Policy Evaluation on“The Pay-For-Performance Program of Hepatitis B and C” in Taiwan

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Nothing Ventured, Nothing Gained – Is The Innovation Fund The Catapult to A New Generation of Care Concepts and A Competitive Market in Health Care in Germany?

    Nov 1, 2016, 00:00

  • Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment Switching

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Indonesian Asthma Patients

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Parallel Export And Its Impact On Availability Of Drugs In Slovakia

    Nov 1, 2016, 00:00

  • The First Indonesian Health-Related Quality of Life Valuation Study- An Eq-5d-5l Value Set

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • General Public Knowledge and Awareness About Medicines Use in Penang, Malaysia

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Changing Patterns of Medication Use at the End of Life in the Elderly

    Nov 1, 2016, 00:00

  • Direct Economic Burden in Patients with Cerebral Venous Thrombosis at A Tertiary Care Hospital in South India

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Market Uptake Of Pharmaceutical Innovations In Germany - Regulatory Approaches And Its Consequences

    Nov 1, 2016, 00:00

  • Analysis on the Regional Distribution of Telemedicine in China

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models- A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 Study

    Nov 1, 2016, 00:00

  • An Observational Study on Risk Factors and Clinical Presentation S In Stroke Patients

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • Incremental Cost-Effectiveness of Algorithm-Driven Genetic Testing Versus no Testing for Maturity Onset Diabetes of the Young (Mody) in Singapore

    Nov 1, 2016, 00:00

  • Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Lower Extremity Functional Scale Among Foot And Ankle Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Treatment Rates in Patients with HER2+ Metastatic Breast Cancer and the Factors Influencing Treatment Decision

    Nov 1, 2016, 00:00

  • Clinical Impact of Antimicrobial Impregnated Catheters For Reduction of Infection In Cerebrospinal Fluid Diversion Procedures

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00

  • Assessing The Clinical And Economic Burden of Prostate Cancer in The United States Veteran Population

    Nov 1, 2016, 00:00

  • The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

    Nov 1, 2016, 00:00

  • Assessing Health-State Utility Values in Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • A Risk-Benefit Analysis of Key Performance-Based Risk Sharing Agreements (PBRSAS) in the EU and US (2002-2016)

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Different Methods, Different Results? Comparing Health Technology Assessments in the United Kingdom and Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas

    Nov 1, 2016, 00:00

  • The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online Data

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

    Nov 1, 2016, 00:00

  • The Patient-Risk of Hypoglycaemia As A Function of Pharmacological Treatments. A Retrospective Analysis on Database Hypothesis

    Nov 1, 2016, 00:00

  • Literature Review on Hospital Costs for Patients Undergoing Gastrectomy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Added Benefit of Upper Airway Stimulation For The Treatment of Moderate To Severe Obstructive Sleep Apnea In Austria

    Nov 1, 2016, 00:00

  • The Evolution And Comparison Of Hta Assesment Organisations In Selected European Countries

    Nov 1, 2016, 00:00

  • The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • The Role of Insulin-Like Growth Factor-1 on Steatohepatitis

    Nov 1, 2016, 00:00

  • Using Acoustic Simulations of Hearing Loss to Describe Health States- Are they Feasible and Reliable to use?

    Nov 1, 2016, 00:00

  • Bio-Similar Or Different? – Understanding The Payer Perspective

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • Investigating The Economic Impact of Sflt-1/PLGF Ratio As A Predictive Test in Women with Suspected Preeclampsia in Italy

    Nov 1, 2016, 00:00

  • Economic and Humanistic Impact Assumptions for Hypoglycemic Events- Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes

    Nov 1, 2016, 00:00

  • The Outcomes of A Pharmaceutical Care Assistance Program in A Romanian Community Pharmacy

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

    Nov 1, 2016, 00:00

  • UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy

    Nov 1, 2016, 00:00

  • Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • Comparison of Three Generic Utility Instruments In Patients With Renal Disease

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to ...

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • Racial Disparities In Access To Pharmacy And Its Services In Pennsylvania

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly

    Nov 1, 2016, 00:00

  • Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • The Increasing Role of Wearable Digital Technology in Disease Management - An Assessment of the Opportunities and Challenges from a Multi-Stakeholder (Patient, Payer, Physician, Manufacturer) Perspective

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In Brazil

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Ranibizumab And Aflibercept For Central RVO- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • PCSK9-Inhibitors- Identification of Eligible Patients from Regional Administrative Healthcare Databases

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los And Costs) of Adhesion Related Complications after Liver Resection Surgery

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Drug Utilization Study of Antibiotics in A Secondary Care Referral Hospital

    Nov 1, 2016, 00:00

  • Approach to Implementation of a Feasible Antibiotic Stewardship Program at a Tertiary University Public Hospital

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00

  • The Relationship Between Target Joints And Non-Drug Direct Costs In Severe Haemophilia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Colorectal Cancer in Slovak Republic

    Nov 1, 2016, 00:00

  • Single-Arm Trials in Systematic Reviews- Are They Adequately Captured by Existing Search Filters?

    Nov 1, 2016, 00:00

  • A 12-Week Cost Analysis to Compare Fluticasone Furoate/Vilanterol And Beclomethasone Dipropionate/Formoterol In The Treatment of Mild-To-Moderate Asthma

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Viacoram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Challenges for HTA Submissions Concerning Conditions Lacking Established Treatment Pathways

    Nov 1, 2016, 00:00

  • Combined use of Administrative Data Flows with Innovative Biologic Drug Registries to Assess Therapeutic Appropriateness- An Italian Regional Experience

    Nov 1, 2016, 00:00

  • Analysis of Hta Requirements Across 10 Emerging and Developed Countries

    Nov 1, 2016, 00:00

  • Pharmaceutical Pricing Strategies In Developing Countries- A Systematic Review

    Nov 1, 2016, 00:00

  • Early Benefit Assessment Of Drugs And The Value-Based Healthcare Concept – A Qualitative Inquiry Within The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System

    Nov 1, 2016, 00:00

  • Management and Outcomes of Acute Kidney Injury

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Scores in Breast Cancer Survivor Women with and without Breast Reconstruction Surgery

    Nov 1, 2016, 00:00

  • Movement of Drugs for Cancer Through The Pharmacoeconomic Evaluation Process in Ireland- Consideration Given to The Quality of Clinical Evidence

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dabigatran for The Prevention of Stroke in Iranian Atrial Fibrillation Patients

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Health Assessment Questionnaire (Haq) in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • Deep Brain Stimulation Compared to Device-Aided Infusion Therapies for Parkinson’s Disease with Early Motor Complications- A UK Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Evaluating Effectiveness And Persistency of A Pharmacist-Led Disease Management Program

    Nov 1, 2016, 00:00

  • Estimating the Value of Treatment for Fabry Disease- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age

    Nov 1, 2016, 00:00

  • Breast Cancer in China- Room for Improved Screening

    Nov 1, 2016, 00:00

  • Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates- Comparison of Results from a Clinician Survey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treatment of Previously Treated PD-l1 Positive Advanced NSCLC Patients

    Nov 1, 2016, 00:00

  • Is There a Justification to Fullfill the Gap in Clinical Pathway of Inflammation and Itching Treatment in Poland - Cost-Utility Analysis (CUA) of Mometasone Furoate Ointment

    Nov 1, 2016, 00:00

  • Is the Orphanage Filling Up? Projecting the Growth and Budget Impact of Orphan Drugs in Europe

    Nov 1, 2016, 00:00

  • Study Care Costs and Use of Health Technologies for Patients with Hemophilia a Health System Affiliates in Colombia

    Nov 1, 2016, 00:00

  • Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma

    Nov 1, 2016, 00:00

  • The Short-Term Health and Economic Burden of Gestational Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Comparison Of The Relationship Between Socio-Economic Status And Health-Related Quality Of Life Amongst Atopic Dermatitis Patients Across Different Healthcare Systems

    Nov 1, 2016, 00:00

  • Reliability and Convergent Validity of The Nei Vfq-25 with and Without Near and Distance Activity Appendix Items In Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

    Nov 1, 2016, 00:00

  • Comparision Of Perception Towrds Generic Medicines Between Final Year Pharmacy And Medical Students In Southeast Yemen

    Nov 1, 2016, 00:00

  • A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2016, 00:00

  • Adoption of Transcatheter Mitral Valve Repair in Germany- Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014

    Nov 1, 2016, 00:00

  • Role Of Tuberculosis Home Observer In Improving Clinical Outcome Of Patient In Yemen

    Nov 1, 2016, 00:00

  • Development of the Musculoskeletal Health Questionnaire (MSK-HQ) for Use in Different Conditions and Different Healthcare Pathways

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)

    Nov 1, 2016, 00:00

  • New Data on the Burden of Abnormal Pap Smears and Hospitalised Pre-Cancerous Lesions in France (EGB AND PMSI DATABASES ANALYSIS)

    Nov 1, 2016, 00:00

  • Economic Burden of Advanced Gastric Cancer (AGC) in Mexico

    Nov 1, 2016, 00:00

  • Treatment Switching Problem in Cancer Clinical Trials – Implications for Health Technology Appraisal Outcomes

    Nov 1, 2016, 00:00

  • Real Life Drug Utilization and Biologics Effectiveness in Patients With Crohn's Disease – A Population-Based Study in Taiwan

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In Greece

    Nov 1, 2016, 00:00

  • Relations between Adherence to Therapy and Quality of Life (Qol) In Cml Patients in Bulgaria

    Nov 1, 2016, 00:00

  • Cancer Associated Medical Spending- US National Data Between 2000 and 2013

    Nov 1, 2016, 00:00

  • Clinical Effectiveness Telepsychotherapy for Depression Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Success and Failure of Straightforward Versus Sophisticated Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spond ...

    Nov 1, 2016, 00:00

  • Pessoa Study – Evaluating The Burden of Psoriasis In Portugal From The Patients’ Perspective (A Patient Reported Outcomes Analysis)

    Nov 1, 2016, 00:00

  • Protective Effect of Metformin Against Tuberculosis in Diabetic Patients

    Nov 1, 2016, 00:00

  • A Systematic Review on the Evidence of Adequate Discount Rates for Vaccines in Germany

    Nov 1, 2016, 00:00

  • The Invariance Analysis Of Sf12v2- ¿Are Comparable The Quality Of Life Results Of Men And Women?

    Nov 1, 2016, 00:00

  • Meta-Analysis of Newer Anti-Epileptic Drugs for Treatment of Partial Epilepsy in Children

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer In Croatia - Cost of Disease Study

    Nov 1, 2016, 00:00

  • Trend Of Antidepressant Utilization In Iran, 2006- 2015

    Nov 1, 2016, 00:00

  • Evaluation of Supportive Care in the Cancer Patients on Chemotherapy in a Developing Country- A Comparision of Clinical Practice with Standard Guidelines

    Nov 1, 2016, 00:00

  • The Effects of Continues Glucose Monitoring System on Patient Outcomes and Associated Costs

    Nov 1, 2016, 00:00

  • A Systematic Review Of Economic Evaluation Alongside Hematopoietic Stem Cell Transplantation In Japan

    Nov 1, 2016, 00:00

  • Developing Item Pools for Physical Functioning, Social Relationships, and Positive Mindset to Measure Health-Related Quality of Life (HRQOL) in the Singapore Population

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tocilizumab Vs Abatacept In Methotrexate-Experienced Patients with Rheumatoid Arthritis In Italy

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Capsule and Injectable Etoposide To The Treatment of Osteosarcoma

    Nov 1, 2016, 00:00

  • Reimbursement of Insulin for Diabetes- Implementation from the Ukrainian Health Care Perspective

    Nov 1, 2016, 00:00

  • A Study Evaluating Living Organ Donors In Kidney And Liver Transplantation

    Nov 1, 2016, 00:00

  • Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

    Nov 1, 2016, 00:00

  • Measuring the Relationship between Hospital Costs and Quality of Care- An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada

    Nov 1, 2016, 00:00

  • Dice Simulation- A New Method that Facilitates Decision-Analytic Modeling

    Nov 1, 2016, 00:00

  • The Cost of Post Stroke Treatment at Selected Public Primary Care Healthcentres In Malaysia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications on Smoking Cessation and Relapses Among Elderly Smokers

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis For The Treatment Of Primary Immunodeficiency Disease (Pidd) In The Mexican Social Security Institute In 2016

    Nov 1, 2016, 00:00

  • Patient-Relevant Endpoints In Psoriasis – A Literature Review Of Patient Preference Studies

    Nov 1, 2016, 00:00

  • Should Patients Estimate Health Related Quality Of Life? The Results Of Empirical Study

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in Italy- A Probabilistic Cost of Illness Analysis

    Nov 1, 2016, 00:00

  • Exercise and Factors Influence Mental Health Of Undergraduated Students At Burapha University In 2014

    Nov 1, 2016, 00:00

  • The Impact Of Increasing Disability On Employment And Caregiver Burden Among Multiple Sclerosis Patients In Brazil

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted by Absenteeism Associated with Insulin Dependent Diabetes Mellitus (IDDM) in Poland

    Nov 1, 2016, 00:00

  • Relapse Rates and Healthcare Resource use of Therapy Persistent And Non-Persistent Multiple Sclerosis Patients In Germany – A Real World Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial

    Nov 1, 2016, 00:00

  • The Frequency of Relapsed or Refractory Disease After Autologous Stem Cell Transplantation in Classical Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan- Comparison of Results From A Clinician Survey

    Nov 1, 2016, 00:00

  • Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Utility In Idiopathic Pulmonary Fibrosis In France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Saxagliptin Versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

    Nov 1, 2016, 00:00

  • Prices And Affordability Of Reimbursed Pharmaceuticals- A European Cross-Country Study

    Nov 1, 2016, 00:00

  • A First Cost-Effectiveness Analysis Based on Real Life Clinical Outcomes of Bevacizumab+ Paclitaxel Compared to Paclitaxel Among French Patients with HER2- Metastatic Breast Cancer in First Line of Treatment

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany

    Nov 1, 2016, 00:00

  • Understanding The Role of Dermatologists And Oncologists In Melanoma Treatment In France and The UK

    Nov 1, 2016, 00:00

  • Attributes Defining Patient Engagement And Centeredness In Health Care Research And Practi A Framework Developed By The Ispor Patient-Centered Special Interest Group

    Nov 1, 2016, 00:00

  • Implications of Total Budget Impact on Oncology Drug Pricing in The us And EU5

    Nov 1, 2016, 00:00

  • Public Consultation as a Tool for Patient and Public Involvement in The Brazilian HTA Process

    Nov 1, 2016, 00:00

  • 5 Year and Long-Term Budget Impact Analysis of New Hepatitis C Therapies from A Payer Perspective in Switzerland

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy

    Nov 1, 2016, 00:00

  • Pharmaceutical Reimbursement Of Innovative Medicinal Products In Belgium

    Nov 1, 2016, 00:00

  • Intravenous (IV) Admnistration of Morphine For Moderate-To-Severe Acute Pain In The Emergency Room (ER) Setting Inflicts A Substantial Economic Burden In The EU5

    Nov 1, 2016, 00:00

  • Acute Cardiovascular Adverse Reaction of Cox-2 Inhibitors Among Osteroarthritis Patients in Taiwan

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Three Regions In Italy

    Nov 1, 2016, 00:00

  • Prevalence, Potential Risk Factors, Sequelae of Diastasis Recti Abdominis and The Treatment

    Nov 1, 2016, 00:00

  • Effect Of Sociodemographic Determinants And Socio-Economic Status On Poliomyelitis Immunization Among Under-Five Children In Pakistan

    Nov 1, 2016, 00:00

  • Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns Among Patients with Ovarian Cancer- An Analysis of a Large us Electronic Health Records Database

    Nov 1, 2016, 00:00

  • Legislative Framework for Reimbursement Conditions for Gene Therapies

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Reduced Ejection Fraction (HF-REF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Subatmospheric Pressure Therapy Efficiency for the Treatment of Pressure Ulcers- A Health Techonology Assessment

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Stroke- An Analysis in Ho Chi Minh City 115 People's Hospital, Vietnam

    Nov 1, 2016, 00:00

  • Budget Impact Model to Augment The Value of An Innovative Device for The Early Detection of Pressure Ulcers in Scotland

    Nov 1, 2016, 00:00

  • Quality of Life in Advanced Melanoma- Results of The Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • Burden of Disease And Management of Mesothelioma In Fran A National Cohort Analysis

    Nov 1, 2016, 00:00

  • What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungary

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge, Attitude And Practice (Kap) Of Pharmacist Regarding Adverse Drug Reaction (Adrs) And Pharmacovigilance In Public Hospitals Quetta

    Nov 1, 2016, 00:00

  • Cost Analysis Of Comorbities- Evidence From A Hiv+ Patients Cohort

    Nov 1, 2016, 00:00

  • A Real Concern Or Just A Hype? – Evidence On Negative Clinical Consequences Of Switching From Originator To Biosimilar Based On A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Impact of State Mandated Queries of The Prescription Drug Monitoring Programs on Opioid And Non-Opioid Drug Related Adverse Effects- A Difference In Difference Approach

    Nov 1, 2016, 00:00

  • Eliciting Individual Patient Preferences on The Benefits and Risks of Cancer Treatments- Results From A Survey Conducted in Myeloma Patients

    Nov 1, 2016, 00:00

  • Drug Utilizaton and Pharmacoeconomic Analysis of Geriatric Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Special Considerations and Patient Access Schemes for Oncology by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Post-Stroke- An Analysis in Hospital of Occupational Diseases and Rehabilitation, Vietnam

    Nov 1, 2016, 00:00

  • Real World use of Biologics Therpies for Patients with Ulcerative Colitis in Japan

    Nov 1, 2016, 00:00

  • A Comparison Of Health State Utilities Among Breast Cancer Patients In Mainland China

    Nov 1, 2016, 00:00

  • Association Between Orphan Drug Prices and Therapeutic Area

    Nov 1, 2016, 00:00

  • Concordance of Health Technology Assessment Recommendations of Diabetes, Hepatitis, Oncology and Epilepsy Pharmaceutical Products by Five Agencies within Europe- An Interrater Reliability and Association Analysis

    Nov 1, 2016, 00:00

  • A Health Policy Study Measuring The Gap Analysis Between The Management of Metastatic Conditions and Other Diseases Under The Egyptian Healthcare Insurance System

    Nov 1, 2016, 00:00

  • Assessment of Awareness and Knowledge of Breast Cancer in Pakistani Females; A Quantitative Study

    Nov 1, 2016, 00:00

  • Differential Patterns of Persistent Opioid Use in Patients with Cancer and Non-Cancer Pain

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in The Guangdong Healthcare Setting in China

    Nov 1, 2016, 00:00

  • Accuracy Of Text Processing Tokenisers For Automated Identification Of Diseases And Interventions In Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China

    Nov 1, 2016, 00:00

  • Colorectal Cancer Treatment Costs in Estonia

    Nov 1, 2016, 00:00

  • Treatment Persistence and Discontinuation Risk of Typical Depot and Atypical Long-Acting Antipsychotics in Patients with Schizophrenia in Poland

    Nov 1, 2016, 00:00

  • Adherence to Drug-Related Monitoring Guidelines for Multiple Sclerosis Therapies- Real-World Evidence From A Us Claims Database

    Nov 1, 2016, 00:00

  • Cancer Prevention- Knowledge And Attitudes Among Healthcare Professionals

    Nov 1, 2016, 00:00

  • Further Validation of the Haemopref in a Real-World Setting

    Nov 1, 2016, 00:00

  • Prospective Utility Study of Patients with Multiple Cardiovascular Events

    Nov 1, 2016, 00:00

  • Novel Oral Anticoagulants in the UK and Fran Comparative Assessment of Costs of Prescriptions Dispensed in the Non-Hospital Setting

    Nov 1, 2016, 00:00

  • Insights from 6 Years' Managed Entry Agreement Experience in Belgium

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Venous Thromboembolism (VTE) Among Hospitalized Patients in China- An Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Development of Hta In Kazakhstan

    Nov 1, 2016, 00:00

  • Risk Factors of Cardiovascular Disease in Malaysian Diabetes Patients

    Nov 1, 2016, 00:00

  • A Review of Studies of Health-Related Quality of Life Performed in Chinese-Speaking Ischemic Heart Disease Patients

    Nov 1, 2016, 00:00

  • Policy Objective of Generic Medicines from the Investment Perspective- The Case of Clopidogrel

    Nov 1, 2016, 00:00

  • To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • The Ethical Issues Of Pharmacogenetic Tests

    Nov 1, 2016, 00:00

  • Measurement Properties of The EQ-5D-5l Compared To The EQ-5D-3L In Psoriasis Patients

    Nov 1, 2016, 00:00

  • CARDIOVASCULAR DISORDERS - Patient-Reported Outcomes Patient Preference StudiesTreatment Patterns and Medication Adherence of Acute Ischemic Stroke Patient in Korea

    Nov 1, 2016, 00:00

  • Review of Economic Evaluation of Saxagliptin in Type2 Diabetes in China

    Nov 1, 2016, 00:00

  • Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D

    Nov 1, 2016, 00:00

  • Quality of Life for Patients Using Hemodialysis (HD) vs. Peritoneal Dialysis (PD) Modalities in Taiwan

    Nov 1, 2016, 00:00

  • The Choice Between HIP Prosthetic Implants in Total HIP Replacement- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • The Sale of Antibiotics Without Prescription In Retail Pharmacies- A Cross-Sectional Survey In Three Cities of China

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Olaparib Use in Patients Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • Patient Reported Health Utility in HR+/HER2- Advanced/Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • The Association Between Parenting Stress And The Child’s Quality of Life Among Parents of Asthmatic Children

    Nov 1, 2016, 00:00

  • Evaluation of Injectable Lanreotide Acetate in The Treatment of Liver Carcinoma

    Nov 1, 2016, 00:00

  • Nine Tests For Assesing Validity Of A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • What Happens To Originator Medicines When (Generic) Followers Enter The Public Market

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Certolizumab Pegol In Adults With Axial Spondyloarthritis In Mexico

    Nov 1, 2016, 00:00

  • Recent Trends In Different Devices, Operating Systems, And Browsers Used By Patients Taking Part In Online Medical Surveys

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal

    Nov 1, 2016, 00:00

  • A Retrospective Observational Cohort Study To Investigate Treatment Outcome of Mrsa Patients Administrated with Anti-Mrsa Drugs using Large Insurance Claims Data in Japan

    Nov 1, 2016, 00:00

  • Developing and Testing A Stated-Preference Instrument to Prioritize Treatment Goals Among Patients with Recent Onset Schizophrenia

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis on Tolerability and Efficacy of Sofosbuvir Containing Regimens in Hepatitis C Patients With Stage 4-5 Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Equity of Government Subsidy in Health Care- A Case Study in China

    Nov 1, 2016, 00:00

  • Measuring Treatment Satisfaction and Preference in Patients with Asthma and Copd- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Medication Reconciliation- A Tool for Better Patient Care

    Nov 1, 2016, 00:00

  • Eliciting Payers Preferences In Central And Eastern Europe- Results Of Mcda Case Study

    Nov 1, 2016, 00:00

  • Adapting Data Sources for Systematic Literature Review Retrieves Additional Data Relevant for Asian HTA

    Nov 1, 2016, 00:00

  • Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as Outcome

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cementless Versus Cemented Prostheses for Total HIP Arthroplasty From A UK Hospital Perspective

    Nov 1, 2016, 00:00

  • Clinical Outcomes of Bipolar Disorder on Long-Term Treatment with Lithium with or without Mood Stabilizers

    Nov 1, 2016, 00:00

  • Project Octo-Pills- Management Of Polypharmacy And Drug Related Problems From Hospital To Community Pharmacies – An Octopus Initiative For The Silver Tsunami

    Nov 1, 2016, 00:00

  • Critical issues influencing cost-effectiveness analyses of pneumococcal vaccine strategy for elderly in japan

    Nov 1, 2016, 00:00

  • Access to Anti-Cancer Drugs In India- Is There a Need to Revise Reimbursement Policies?

    Nov 1, 2016, 00:00

  • Comparative Safety and Effectiveness of Telemonitoring Intervention Versus Usual Care for Heart Failure- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Beyond Cervical Cancer- The Cost-Effectiveness Of Hpv Vaccination In The Netherlands

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

    Nov 1, 2016, 00:00

  • patient Characteristics and Treatment Patterns of Venous Thromboembolism (Vte) Among Hospitalized Patients in China- an Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • A New Model to Identify Multivariate Causes of High Cost in Patient With Advanced Liver Disease

    Nov 1, 2016, 00:00

  • Patient Reported Asthma Control In Comparison To Physician Assessed Asthma Control- A Cross-Sectional Analysis of The Act Questionnaire Based on 673 Asthma Patients

    Nov 1, 2016, 00:00

  • Systematic Review, Meta-Analysis, and Cost-Effectiveness Model of Invasive Versus Non-Invasive Strategy for Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) in Patients with Prior Coronary Artery Bypass Graft (CABG)

    Nov 1, 2016, 00:00

  • The Probabilistic Efficiency Frontier- A Value Assessment Of Treatment Options In Hepatitis C

    Nov 1, 2016, 00:00

  • Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

    Nov 1, 2016, 00:00

  • Hyperbolic Discounting of Effects in Economic Evaluations

    Nov 1, 2016, 00:00

  • Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma

    Nov 1, 2016, 00:00

  • Baseline Characteristics and Survival of Patients Diagnosed with Advanced NSCLC in Sweden Between 2006 and 2013, Matched (1-4) To A Comparison Cohort From The General Population

    Nov 1, 2016, 00:00

  • Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results

    Nov 1, 2016, 00:00

  • Retrospective Study of Frequency and Cost of Multiple Myeloma (MM) Complications and Treatment Related Adverse Events (AES)

    Nov 1, 2016, 00:00

  • Insights for Care- Comparison of Healthcare Utilisation and Cost Impact of Managing Diabetes Patients with Hypoglycaemia to Patients with Heart Failure or Stroke Using Real-World Evidence Data from an Urban Healthcare System in Birmingham, ...

    Nov 1, 2016, 00:00

  • Cost of Treatment Hypertention Inpatients in Vietnam

    Nov 1, 2016, 00:00

  • A Comparison of National Guidelines for Network Meta Analysis

    Nov 1, 2016, 00:00

  • Positive Impact of Indacaterol Launch on Guidelines Compliance And Consequences on COPD Daily Treatment Cost In France

    Nov 1, 2016, 00:00

  • Application of Healthcare Failure Mode Effect Analysis in Improving Patient Education at an Outpatient Department af a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Preferences For Treatment Attributes Of Dulaglutide And Liraglutide Among Patients With Type 2 Diabetes Mellitus And Their Willingness To Self-Inject Diabetes Medication- A Comparison Between Japan And The United Kingdom

    Nov 1, 2016, 00:00

  • Validity Of The Eq-5d-Youth In Asthmatic Children

    Nov 1, 2016, 00:00

  • A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies

    Nov 1, 2016, 00:00

  • European Regulators and Payers Initiatives for Drug Access- Collaborations or Divergences?

    Nov 1, 2016, 00:00

  • Psychometric Evaluation of Clinical Outcomes Assessments in A Phase II Trial

    Nov 1, 2016, 00:00

  • A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Gazyvaro in Association to Chlorambucil for Patients with Chronic Lymphocytic Leukemia When Full-Dose Fludarabine is Unsuitable in France

    Nov 1, 2016, 00:00

  • Evaluation of Antibacterial and Cytotoxic Effects of Gymnema Sylvestre R.BR. Species Cultivated in Pakistan Against Common Resistant Pathogens

    Nov 1, 2016, 00:00

  • Overview of the Budget Impact Analysis of Drugs in Hungary and Internationally

    Nov 1, 2016, 00:00

  • Table of Contents

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis on Hepatic Carcinoma Patients with Hepatitis C

    Nov 1, 2016, 00:00

  • Trading-Off Quality of Life and Survival Time – Feasibility of Web-Based Discrete Choice Experiments For QLU-C10D Utility Elicitation in Cancer Patients

    Nov 1, 2016, 00:00

  • Dexhelpp - Aging Population- Routine Data Based Analyses Of Fractures Due To Falls Less Than Three Meters – Hospitalization, Readmission And Mortality

    Nov 1, 2016, 00:00

  • "Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of Coas

    Nov 1, 2016, 00:00

  • Assessment of Community Pharmacy Services in Malaysia- Perspectives from Community Pharmacists, General Practitioners, Consumers and Health Policy Stakeholders

    Nov 1, 2016, 00:00

  • Pegaspargase Versus Asparaginase In Childhood Acute Lymphoblastic Leukemia- A Cost-Minimization Analysis In France

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor for The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Biosimilars In A Belgian Tertiary Care Hospital- A Simulation

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Modified Mobility Section Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • Hba1c Variability Predicts Short-Term Risk of Albuminuria In Patients with Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Ebola Virus Disease and Its Management- A Review

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Amritha Guggulu in the Management of Gout

    Nov 1, 2016, 00:00

  • An Economic Model of Advance Care Planning- A Cost Effective Intervention for People with Dementia

    Nov 1, 2016, 00:00

  • Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population Sizes

    Nov 1, 2016, 00:00

  • A Study on Evaluation of Effects of Anti-Tubercular Drugs on Hematological and Hepato-Renal Functions in Tuberculosis Patients

    Nov 1, 2016, 00:00

  • The Economic Value of Rapid Deployment Aortic Valve Replacement Via Full Sternotomy

    Nov 1, 2016, 00:00

  • Generic drugs- do they offer the same safety and efficacy as originator medicines? -perceptions and attitudes of final year pharmacy students in greece

    Nov 1, 2016, 00:00

  • Cost Analysis of Intrathecal Baclofen Therapy For The Treatment of Spastic Cerebral Palsy In The Russian Federation

    Nov 1, 2016, 00:00

  • EU5 Patient's Willingness to Try New Techniques for Managing their Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Irrational Use of Antibiotics in Turkey

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Opportunities For Pharmaceutical Companies To Successfully Launch Products In African Countries

    Nov 1, 2016, 00:00

  • The Role of Budget Impact on HTA Rejection of Oncology Drugs in Romania

    Nov 1, 2016, 00:00

  • Costs Evolution Of Cancer Therapies In Europe From 2004 To 2014

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol Use and Indications in the Netherlands

    Nov 1, 2016, 00:00

  • Economic Value of Eptfe Stent-Grafts Compared to Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in England

    Nov 1, 2016, 00:00

  • A Cost Effectiveness Analysis of Rosuvastatin Against Atorvastatin in Cardiovascular Diseases and Stroke- An Ambispective Study

    Nov 1, 2016, 00:00

  • One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Servi The Lucky Bone™ Program

    Nov 1, 2016, 00:00

  • Changes In The Capacity Of Neurological And Psychiatric Inpatient Care In Hungary Between 1990 And 2014

    Nov 1, 2016, 00:00

  • Treatment Pattern of Antibiotics and Cost Analysis in Sepsis Patients- A Cross Sectional Retrospective Prospective Study

    Nov 1, 2016, 00:00

  • Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador

    Nov 1, 2016, 00:00

  • An Investigation Into Open-Source Modelling In Health Economics- Opportunities And Challenges

    Nov 1, 2016, 00:00

  • The Association Between Initiation of Guideline Recommended First-Line Systemic Therapy and Healthcare Costs and Utilization in a Metastatic Non-Small Cell Lung Cancer (MNSCLC ) Population

    Nov 1, 2016, 00:00

  • The Prevalence of Atypical Antipsychotic Medication Use For Pediatric Psychosis in Korea

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Punarnavadi Mandoora And Tryushanadi Loha in Patients of Obesity

    Nov 1, 2016, 00:00

  • All-Cause Mortality and Cardiovascular Events After Acute Myocardial Infarction and 12-Months Dual Platelet-Aggregation Inhibition in Clinical Practice. Findings from the Piper Study

    Nov 1, 2016, 00:00

  • Health Technology Assessments of Lama/Laba Combination Products

    Nov 1, 2016, 00:00

  • The Adoption Trends of Robotic-Assisted Benign Hysterectomy in United States From 2008 to 2014

    Nov 1, 2016, 00:00

  • Traditional and Complementary Medicine Use Among Women to Conceive and During Pregnancy- A Literature Review

    Nov 1, 2016, 00:00

  • A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly

    Nov 1, 2016, 00:00

  • Application of Risk Adjusted Cost-Effectiveness Analyses for Stroke Treatment

    Nov 1, 2016, 00:00

  • Modelling The Economic Impact of Implementing Treatment-Free Remission (TFR) In Philadelphia+ (PH+) Chronic Myelogenous Leukemia In Chronic Phase (CML-CP) Patients Treated In First Line (1l) With The Tyrosine Kinase Inhibitors (TKI)- Imatin ...

    Nov 1, 2016, 00:00

  • A New Coverage with Evidence Development Dedicated to Innovative Medical Biology and Pathological Anatomy and Cytology Procedures in Fran Overview of the Situation after one Year of Implementation and Focus on Innovative Genetics Procedures ...

    Nov 1, 2016, 00:00

  • what Do we Pay for Compounded Drugs?

    Nov 1, 2016, 00:00

  • Sick Leave and Disability Pension in Patients with Chronic Hepatitis C Compared with Matched General Population Comparators- A Nationwide Population-Based Register Study

    Nov 1, 2016, 00:00

  • France-Spain Comparison of Hospital Delivery Mode Between 2006 And 2014 According Comorbidity Profiles of Patients

    Nov 1, 2016, 00:00

  • Review of Health Technology Assessment (HTA) Requirements for Rare Diseases Across European Countries

    Nov 1, 2016, 00:00

  • Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)

    Nov 1, 2016, 00:00

  • Analysis of Orphan Drugs Reimbursement in Major European HTA Agencies

    Nov 1, 2016, 00:00

  • Avoidable Hospitalizations Through Effective Primary Care At A Pediatric Hospital In The Colombian Caribbean

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Injecting A "Dexamethasone Ropivacaine" Mixture Subcutaneously In The Management of Traumatic Bone Surgeries of The Forefoot

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Transfemoral Aortic Valve Implantation Compared with Surgical Aortic Valve and Medical Management in Patients with Severe Symptomatic Aortic Stenosis in Australia

    Nov 1, 2016, 00:00

  • Too Old for Treatment- Ageism in Chronic Lymphocytic Leukemia (CLL). A Narrative review of the Literature

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain- Pazopanib vs. Sunitinib

    Nov 1, 2016, 00:00

  • Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tiotropium/Olodaterol Administrated Through The Respimat Inhaler As Maintenance Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) In Poland

    Nov 1, 2016, 00:00

  • Potential Efficacy of Lomitapide, A MTP (Microsomal Triglyceride Transfer Protein) Inhibitor, on Survival in Homozygous Familial Hypercholesterolaemia (HOFH)- Results of an Event Modelling Analysis

    Nov 1, 2016, 00:00

  • “Best Supportive Care” or “Therapy According to Physician's Choice” as Appropriate Comparator for German HTA Dossiers – An Underestimated Chance or Risk for the Benefit Assessment?

    Nov 1, 2016, 00:00

  • Beyond Risk-Based Vaccination Policies - A Life-Course Approach to Vaccination

    Nov 1, 2016, 00:00

  • Defining Episodes of Care for Chronic Diseases- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Methodology of Research to Determine Cost and Utility of Pilot One-Stop Fertility Clinic Versus Traditional NHS Fertility Investigation Pathway

    Nov 1, 2016, 00:00

  • Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making

    Nov 1, 2016, 00:00

  • Indirect Costs Associated with Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France

    Nov 1, 2016, 00:00

  • Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure- A Population-Based Study

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece

    Nov 1, 2016, 00:00

  • Quantifying the Economic Burden of Chronic Spontaneous Urticaria in Portugal – What is the Impact on the Portuguese NHS and in the Society

    Nov 1, 2016, 00:00

  • Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Oedema in Spain

    Nov 1, 2016, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment- A Comparative Study of 6 HTA Agencies

    Nov 1, 2016, 00:00

  • Cost‐Utility Analysis Of Ulipristal Acetate (5 Mg) For Long-Term Treatment Of Moderate To Severe Symptoms Of Uterine Fibroids In Portugal

    Nov 1, 2016, 00:00

  • How Are Fast-Track Programmes Like Rapid Recovery Delivering Value Across Hospitals, Cultures And Healthcare Systems In Orthopedics Within A Cost-Constrained Environment?

    Nov 1, 2016, 00:00

  • Indirect Cost Of Hiv/Aids- Results Of A Survey From A Turkish Research Center

    Nov 1, 2016, 00:00

  • Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea

    Nov 1, 2016, 00:00

  • Population Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • How To Select The Best Comparator? An International Economic Evaluation Guidelines Comparison

    Nov 1, 2016, 00:00
  • «
  • 81 (current)
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »